DIVISLAB's weekly performance was disappointing, with a return of -2.65% and a max drawdown of -2.65%, indicating a decline in value. The stock's volatility was relatively low at 5.9%, but its Sharpe ratio of -1.80 suggests that the return was not justified by the risk taken. Compared to its peers, DIVISLAB underperformed DRREDDY and was in line with CIPLA and SUNPHARMA. Overall, the stock was moderately risky this week.

[Volatility: 5.9%]